C Frank Bennett Ionis Pharmaceuticals Inc (IONS) insider trading activity

IONS Quotes by TradingView

C Frank Bennett is EVP, Chief Scientific Officer of IONIS PHARMACEUTICALS INC. Currently has a direct ownership of 93,146 shares of IONS, which is worth approximately $3.09 Million. The most recent transaction as insider was on Jan 18, 2022, when has been sold 6,726 shares (Common Stock) at a price of $30.12 per share, resulting in proceeds of $202,587. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 93.1K
17.01% 3M change
17.79% 12M change
Total Value Held $3.09 Million

C FRANK BENNETT Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 18 2022
SELL
Payment of exercise price or tax liability
$202,587 $30.12 p/Share
6,726 Reduced 10.92%
54,887 Common Stock
Jan 18 2022
BUY
Exercise of conversion of derivative security
-
18,842 Added 23.42%
61,613 Common Stock
Aug 31 2021
BUY
Other acquisition or disposition
$5,104 $33.8 p/Share
151 Added 0.35%
42,771 Common Stock
Feb 26 2021
BUY
Other acquisition or disposition
$4,988 $44.54 p/Share
112 Added 0.26%
42,620 Common Stock
Jan 15 2021
SELL
Payment of exercise price or tax liability
$336,305 $61.28 p/Share
5,488 Reduced 11.43%
42,508 Common Stock
Jan 15 2021
BUY
Exercise of conversion of derivative security
-
15,520 Added 24.43%
47,996 Common Stock
Dec 04 2020
SELL
Open market or private sale
$405,615 $51.04 p/Share
7,947 Reduced 19.66%
32,476 Common Stock
Dec 04 2020
BUY
Exercise of conversion of derivative security
$316,847 $39.87 p/Share
7,947 Added 16.43%
40,423 Common Stock
Dec 02 2020
SELL
Open market or private sale
$361,960 $51.32 p/Share
7,053 Reduced 17.84%
32,476 Common Stock
Dec 02 2020
BUY
Exercise of conversion of derivative security
$281,203 $39.87 p/Share
7,053 Added 15.14%
39,529 Common Stock
Nov 03 2020
SELL
Open market or private sale
$701,550 $46.77 p/Share
15,000 Reduced 31.59%
32,476 Common Stock
Nov 03 2020
BUY
Exercise of conversion of derivative security
$598,050 $39.87 p/Share
15,000 Added 24.01%
47,476 Common Stock
CFB

C Frank Bennett

EVP, Chief Scientific Officer
Carlsbad, CA

Track Institutional and Insider Activities on IONS

Follow IONIS PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IONS shares.

Notify only if

Insider Trading

Get notified when an Ionis Pharmaceuticals Inc insider buys or sells IONS shares.

Notify only if

News

Receive news related to IONIS PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IONS